XML 10 R2.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED BALANCE SHEETS - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 776,000 $ 1,537,000
Other current assets 30,000 18,000
Total current assets 806,000 1,555,000
Other assets:    
Due from related parties 16,000 15,000
Investments in unconsolidated entities 185,000 157,000
Total other assets 201,000 172,000
Property and equipment:    
Operating lease right-of-use asset 0 20,000
Total property and equipment 0 20,000
TOTAL ASSETS 1,007,000 1,747,000
Current liabilities:    
Operating lease right-of-use liability - current portion 0 23,000
Accounts payable and accrued expenses 7,000 86,000
Income taxes payable 170,000 171,000
Total current liabilities 177,000 280,000
Guarantee liability 11,000 11,000
Total liabilities 188,000 291,000
EQUITY    
Common stock - par value $.01; 25,000,000 shares authorized; 7,892,185 and 7,842,185 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively. 79,000 78,000
Additional paid-in capital 2,871,000 2,871,000
Accumulated deficit (2,252,000) (1,710,000)
U.S. Neurosurgical Holdings, Inc. stockholders' equity 698,000 1,239,000
Noncontrolling interests 121,000 217,000
Total stockholders' equity 819,000 1,456,000
TOTAL LIABILITIES AND EQUITY $ 1,007,000 $ 1,747,000
Related Party [Member]    
Other assets:    
Financing Receivable, after Allowance for Credit Loss, Noncurrent, Related Party, Type [Extensible Enumeration] Due from related parties